Champions Oncology, Inc. (CSBR)
NASDAQ · Healthcare
Champions Oncology, Inc. Income Statement 2018–2025
| Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenue | 56.9M | 50.2M | 53.9M | 49.1M | 41.0M | 32.1M | 27.1M | 20.2M |
| Gross Profit | 28.6M | 20.8M | 24.3M | 25.5M | 19.6M | 15.1M | — | — |
| Profitability | ||||||||
| Operating Income | 4.6M | -7.4M | -5.3M | 607,000 | 366,000 | -1.9M | 270,000 | -1.4M |
| EBITDA | 6.2M | -5.5M | -3.2M | 2.1M | 1.3M | -1.1M | 876,000 | -994,000 |
| Net Income | 4.7M | -7.3M | -5.3M | 548,000 | 362,000 | -2.1M | 128,000 | -1.5M |
| Per Share Data | ||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 14M | 14M | 14M | 14M | 15M | 12M | 14M | 11M |
Champions Oncology, Inc. Income Statement — FAQ
Champions Oncology, Inc. (CSBR) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CSBR's income statement history?
The chart and table above show Champions Oncology, Inc.'s income statement by year and by quarter, including the growth rate.